Multiple endocrine neoplasia type 1 (MEN1)

panel MEN1 syndromes (MEN1)

This test is available for the following conditions:

• Conditions > Endocrine > Multiple endocrine neoplasia type 1 (MEN1)
• Conditions > Oncogenetics > Multiple endocrine neoplasia type 1 (MEN1)

Turnaround time
3 weeks

Method

• Sequence analysis of all coding exons and flanking intron-exon boundaries
• CNV analysis of all genes based on NGS

Remarks
This test includes analysis of the following 7 genes: AIP, CDC73, CDKN1A, CDKN1B, CDKN2B, CDKN2C and MEN1.
Panel version: DG 3.6

Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA

---

MEN1 - multiple endocrine neoplasia type 1

This test is available for the following conditions:

• Conditions > Endocrine > Multiple endocrine neoplasia type 1 (MEN1)
• Conditions > Oncogenetics > Multiple endocrine neoplasia type 1 (MEN1)

This product is also part of the following panels:

• WES hereditary cancer (100.0% *)
• WES hereditary cancer (100.0% *)
• WES Mendelian inherited disorders (100.0% *)
• WES Mendelian inherited disorders (100.0% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

• Sequence analysis of all coding exons and flanking intron-exon boundaries
• Deletion/duplication analysis (MLPA)

OMIM: 613733
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane

---